132 related articles for article (PubMed ID: 7001860)
21. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
[TBL] [Abstract][Full Text] [Related]
22. Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.
Long RG; Bryant MG; Yuille PM; Polak JM; Bloom SR
Gut; 1981 Jun; 22(6):505-11. PubMed ID: 7021331
[TBL] [Abstract][Full Text] [Related]
23. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
[No Abstract] [Full Text] [Related]
24. Serum peptide profiles in patients with carcinoid tumors.
Calhoun K; Toth-Fejel S; Cheek J; Pommier R
Am J Surg; 2003 Jul; 186(1):28-31. PubMed ID: 12842744
[TBL] [Abstract][Full Text] [Related]
25. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
26. Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients.
Kastrup J; Henriksen JH; Pedersen JH; Fahrenkrug J; Schaffalitzky de Muckadell OB; Schwartz T; Parving HH; Christensen NJ
Clin Sci (Lond); 1986 Oct; 71(4):411-9. PubMed ID: 2428557
[TBL] [Abstract][Full Text] [Related]
27. Distribution of vasoactive intestinal polypeptide-, substance P-, enkephalin and neurotensin-like immunoreactive nerves in the chicken gut during development.
Saffrey MJ; Polak JM; Burnstock G
Neuroscience; 1982 Jan; 7(1):279-93. PubMed ID: 6176901
[TBL] [Abstract][Full Text] [Related]
28. Dopamine-beta-hydroxylase-, neurotensin-, substance P-, vasoactive intestinal polypeptide- and enkephalin-immunohistochemistry of paravertebral and prevertebral ganglia in the cat.
Heym C; Reinecke M; Weihe E; Forssmann WG
Cell Tissue Res; 1984; 235(2):411-8. PubMed ID: 6200232
[TBL] [Abstract][Full Text] [Related]
29. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
[TBL] [Abstract][Full Text] [Related]
30. Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve.
Lundberg JM; Hökfelt T; Kewenter J; Pettersson G; Ahlman H; Edin R; Dahlström A; Nilsson G; Terenius L; Uvnäs-Wallensten K; Said S
Gastroenterology; 1979 Sep; 77(3):468-71. PubMed ID: 378753
[TBL] [Abstract][Full Text] [Related]
31. Enkephalin and neurotensin: immunohistochemical localization and identification of an amygdalofugal pathway.
Uhl GR; Goodman RR; Kuhar MJ; Snyder SH
Adv Biochem Psychopharmacol; 1978; 18():71-87. PubMed ID: 645467
[No Abstract] [Full Text] [Related]
32. Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept.
Said SI
Clin Endocrinol (Oxf); 1976; 5 Suppl():201S-204S. PubMed ID: 29733
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide and watery-diarrhoea syndrome.
Bloom SR; Polak JM; Pearse AG
Lancet; 1973 Jul; 2(7819):14-6. PubMed ID: 4123289
[No Abstract] [Full Text] [Related]
34. A case of watery diarrhoea syndrome due to an adrenal phaeochromocytoma secreting vasoactive intestinal polypeptide with coincidental autoimmune thyroid disease.
Fisher BM; MacPhee GJ; Davies DL; McPherson SG; Brown IL; Goldberg A
Acta Endocrinol (Copenh); 1987 Mar; 114(3):340-4. PubMed ID: 3564836
[TBL] [Abstract][Full Text] [Related]
35. VIP: the cause of the watery diarrhoea syndrome.
Modlin IM; Bloom SR; Mitchell S
Adv Exp Med Biol; 1978; 106():195-201. PubMed ID: 213959
[No Abstract] [Full Text] [Related]
36. Gastro-intestinal and neurohormonal peptides in the alimentary tract and cerebral complex of Ciona intestinalis (Ascidiaceae).
Fritsch HA; Van Noorden S; Pearse AG
Cell Tissue Res; 1982; 223(2):369-402. PubMed ID: 6279305
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).
Long RG; Bryant MG; Mitchell SJ; Adrian TE; Polak JM; Bloom SR
Br Med J (Clin Res Ed); 1981 May; 282(6278):1767-71. PubMed ID: 6786616
[TBL] [Abstract][Full Text] [Related]
38. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
39. Peptide neurons in the autonomic nervous system.
Schultzberg M; Hökfelt T; Lundberg JM
Adv Biochem Psychopharmacol; 1980; 25():341-8. PubMed ID: 6160734
[No Abstract] [Full Text] [Related]
40. [WDHA syndrome (watery diarrhea, hypokalemia and achlorhydria) with high VIP contents in the blood and tumor tissue--a case study].
Kawanaka M; Ooiwa N; Toyooka K; Matsuoka T; Mori T; Kakishita E; Nagai K; Sugahara I; Okazora T; Ueki S; Kyo A; Suzuki E; Toyosaka A; Okamoto E; Yamaguchi K; Abe K; Kameya T
Nihon Rinsho; 1978; 36(3):656-62. PubMed ID: 650946
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
